NCT00770185 2023-08-04
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Canadian Cancer Trials Group
Phase 2 Completed
Canadian Cancer Trials Group
Cancer Research UK
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)